Geistek

Geistek is a private, revenue-generating CRO founded in 2018, specializing in supporting life sciences companies in the medical device and drug delivery sectors. The company offers end-to-end services including regulatory affairs, clinical trial management, medical writing, data management, and strategic study design, primarily operating across Western Europe. Positioning itself as a flexible and scalable partner, Geistek aims to reduce complexity and accelerate development timelines for its clients from startup to large corporate entities. Its business model is entirely service-based, acting as an outsourced extension of its clients' R&D and regulatory teams.

Integrated CRO service platform combining regulatory strategy, clinical trial management, data science/AI analytics, medical writing, and strategic study design for end-to-end drug and device development support.

Geistek competes in the fragmented CRO market, facing large global players (e.g., IQVIA, ICON) with vast resources and smaller niche consultancies. Its differentiation is its integrated '360°' service model focused on strategic partnership and a specific emphasis on the medical device and drug delivery sectors within Western Europe.